Inspire Medical Systems, Inc. (NYSE:INSP) Shares Purchased by TriaGen Wealth Management LLC

TriaGen Wealth Management LLC boosted its stake in shares of Inspire Medical Systems, Inc. (NYSE:INSP) by 5.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,137 shares of the company’s stock after buying an additional 110 shares during the period. TriaGen Wealth Management LLC’s holdings in Inspire Medical Systems were worth $396,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the stock. True Wealth Design LLC purchased a new stake in shares of Inspire Medical Systems during the 3rd quarter valued at approximately $30,000. Farther Finance Advisors LLC raised its position in Inspire Medical Systems by 1,158.3% in the third quarter. Farther Finance Advisors LLC now owns 151 shares of the company’s stock valued at $32,000 after purchasing an additional 139 shares during the period. GAMMA Investing LLC raised its position in Inspire Medical Systems by 559.3% in the third quarter. GAMMA Investing LLC now owns 178 shares of the company’s stock valued at $38,000 after purchasing an additional 151 shares during the period. Quarry LP lifted its stake in shares of Inspire Medical Systems by 105.4% in the 2nd quarter. Quarry LP now owns 343 shares of the company’s stock valued at $46,000 after purchasing an additional 176 shares during the last quarter. Finally, Signaturefd LLC grew its holdings in shares of Inspire Medical Systems by 45.9% during the 3rd quarter. Signaturefd LLC now owns 270 shares of the company’s stock worth $57,000 after purchasing an additional 85 shares during the period. 94.91% of the stock is currently owned by hedge funds and other institutional investors.

Inspire Medical Systems Trading Down 0.4 %

Shares of NYSE INSP opened at $193.90 on Friday. The stock has a market cap of $5.81 billion, a P/E ratio of 181.22 and a beta of 1.32. The stock has a 50 day moving average of $190.11 and a two-hundred day moving average of $187.98. Inspire Medical Systems, Inc. has a twelve month low of $123.00 and a twelve month high of $257.40.

Inspire Medical Systems (NYSE:INSP) last announced its earnings results on Monday, November 4th. The company reported $0.60 EPS for the quarter, beating analysts’ consensus estimates of $0.06 by $0.54. Inspire Medical Systems had a net margin of 4.37% and a return on equity of 5.30%. The business had revenue of $203.20 million during the quarter, compared to analysts’ expectations of $197.59 million. During the same period in the prior year, the company earned ($0.29) earnings per share. The business’s revenue was up 32.6% compared to the same quarter last year. As a group, research analysts predict that Inspire Medical Systems, Inc. will post 1.35 earnings per share for the current year.

Wall Street Analyst Weigh In

Several analysts recently weighed in on INSP shares. Stifel Nicolaus dropped their target price on shares of Inspire Medical Systems from $200.00 to $190.00 and set a “hold” rating for the company in a report on Tuesday, January 21st. Bank of America upgraded Inspire Medical Systems from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $220.00 to $255.00 in a report on Wednesday, November 20th. Wells Fargo & Company increased their target price on Inspire Medical Systems from $187.00 to $198.00 and gave the stock an “equal weight” rating in a research note on Tuesday, November 5th. Robert W. Baird lifted their target price on Inspire Medical Systems from $240.00 to $252.00 and gave the company an “outperform” rating in a research report on Tuesday, November 5th. Finally, KeyCorp reissued an “overweight” rating and set a $234.00 price target (down previously from $236.00) on shares of Inspire Medical Systems in a research report on Friday, January 24th. Three equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $231.45.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.